Home > Financial Ratios > WOCKHARDT

WOCKHARDT
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for WOCKHARDT
Please provide your vote to see the results

WOCKHARDT Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 272.95-45.29-29.87360.87-56.28

What is the latest Core EBITDA Growth ratio of WOCKHARDT ?

The latest Core EBITDA Growth ratio of WOCKHARDT is 272.95 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar2025272.95
Mar2024-45.29
Mar2023-29.87
Mar2022360.87
Mar2021-56.28

How is Core EBITDA Growth of WOCKHARDT Trending?

Years Core EBITDA Growth % Change
Mar2025 272.95
Positive
Mar2024 -45.29
Negative
Mar2023 -29.87
Negative
Mar2022 360.87
Positive
Mar2021 -56.28 -

Other Financial Ratios of WOCKHARDT


Compare Core EBITDA Growth ratio of peers of WOCKHARDT

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
WOCKHARDT ₹24,629.3 Cr 2.6% -16.7% 52.9% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹389,172.0 Cr 1.8% -3.6% -7.1% Stock Analytics
DIVIS LABORATORIES ₹158,248.0 Cr -2.8% -12.1% 24% Stock Analytics
CIPLA ₹122,835.0 Cr 2.3% 2.4% -4.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹122,793.0 Cr 2.9% 6.5% 8.3% Stock Analytics
DR REDDYS LABORATORIES ₹101,869.0 Cr 2% -2.4% -13.1% Stock Analytics


WOCKHARDT Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
WOCKHARDT

2.6%

-16.7%

52.9%

SENSEX

-0.6%

-2.8%

1.7%


You may also like the below Video Courses